Solum Healthcare Signs MOU With South Africa's 'Tecpro Health'... Africa's AI Cancer Early Diagnosis Market is in full swing

*This content was translated by AI.

- South Africa's largest distributor of medical devices... Laying the foundation for commercialization in sub-Saharan Africa

- Promotion of cooperation in localization in all directions such as clinical research, licensing, and establishment of KOL networks

Solum Healthcare (CEO Kim Ji-hee), an AI-based early cancer diagnosis company, announced on the 1st that it has signed a memorandum of understanding (MOU) with "Tecpro Health," the largest distributor of medical devices and diagnostic kits in South Africa (hereinafter referred to as South Africa).

Tech Pro Health is the largest distributor specializing in medical devices in South Africa with a wide distribution network and logistics infrastructure. Based on its 25 years of exclusive distribution of HIV and syphilis rapid testing kits from global diagnostic company SD Biosensor, it has a strong network with local medical institutions and government departments. Through this, it is playing a key partner in supporting global medical companies' entry into the African market.

Through this MOU, the two companies plan to cooperate in all directions to establish urine-based AI cancer diagnosis solutions, a core technology of Solum Healthcare, in the South African market. In particular, the two companies agreed to continue close cooperation in a wide range of areas, including planning and implementing joint clinical research as well as establishing commercialization strategies for entering the South African market.

Following its cooperation with Egypt's Gustave Lucy Hospital in November last year, Solum Healthcare is focusing on expanding global supply chains beyond the Middle East and North Africa (MENA) regions to sub-Saharan Africa. In the future, it plans to use Tech Pro Health's distribution network to supply products to major hospitals and research institutes in South Africa.

Lunga Makhaye, TechPro Health Director, said, "Solum Healthcare's AI diagnosis platform will be a groundbreaking way to increase the early detection rate of cancer in the African market with a large medical infrastructure gap. We will actively support the technology to be quickly distributed to the medical field based on its strong distribution competitiveness in South Africa."

Kim Ji-hee, CEO of Solum Healthcare, said, "The partnership with South Africa's largest distributor means that our technology has entered the global commercialization stage," adding, "We will do our best to ensure that African patients can enjoy easier and more accurate early diagnosis by completing the local clinical and licensing process without a hitch."

<© STARNEWS. All rights reserved. No reproduction or redistribution allowed.>

*This content was translated by AI.